michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Dana. Martin?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Sure. Yes. I mean I think, well, first of all, I'm quite pleased that the business grew 17% in the quarter. That was good to see. I mean we have a very robust pipeline in IT monetization, Joe. We, I think we, the pipeline is north of $1.5 billion, I think it said record high this quarter. The awards can be lumpy, but I think I'm confident that's going to remain a significant growth driver for us here as we look to the future and look to the long term. As I've said before, I think we're in the third or fourth inning here in the federal government of modernizing IT platforms, including civilian platforms. And so I think it's a positive long-term trend for us. So I remain, I think we remain very excited and very positive on that market.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. This is an excellent question. Indeed, roxa has been included in a number of the clinical guidelines in China. It is included together with ESAs and other treatments. But as you know, I think for new product, this inclusion becomes critical. I think how roxa is described, I -- we are very pleased with that. The mention that we made related to becoming standard of care relates to basically just looking at the share performance that we're having. When we look at the last few months, basically, now roxadustat is the largest brand by value in China.
It has about a 33%, 34% share by value and it's continually increasing. Clearly, our aspiration is still higher. And I think what's important, I think, is when we look at the market is -- not just that we're capturing share but since roxadustat was launched and reimbursed, we've seen an expansion of the market. In fact, an expansion are of -- even ESAs are growing at faster rates. So there is the increased promotion of roxadustat and anemia CKD. Clearly, there's a lot of unmet need, and we basically have seen that reflected in the marketplace in China. So we are very pleased in terms of where we are on the -- withstanding the progress today in China.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So Brandon, maybe I can make it quick, it's Andy speaking. We had a strong Q1. We had a strong start last year, and that included some of the carryover from the COVID19 -- the cyber ninth attack in December of 2019. Actually, we were pretty pleased with the recovery of the diagnostics business in Q1 and it's fairly broad-based, but I would say more so in Asia Pac as that was the first region that started to show a negative impact in 2020. So I'd say it's meeting -- it's really meeting our expectations for our guidance for the year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Emily, well, first and foremost, it's a really cool company. And we're glad we got to bring them to the family of companies. It's a little different, but it's still distribution, some different products. They go to market differently. And as you well know, we don't buy good companies and change the name and screw them up in any way. We like them for a reason. So we think this is a really good company. We have opportunities to perhaps do acquisitions. We'll see how that all works out. But they complement our company because they serve the same markets, but they do it differently. It's an adjacent business. I've said that before. I hope nobody takes that as that's all we're going to do. We're going to continue to look for really fine companies. And this happens to be one of them. And we hope that they'll grow and they have a great management team and the way they go to market is a little bit different, and that's OK.
But the products they sell are into the similar markets, the rest of the FOC sells into, but the products are different. You mentioned copper and plastic. They also do conduit and a couple of other things into the -- not only just nonres, but they also do residential and those type of things. So I mean that would be my comments. But Karla runs it, so if you could probably add to that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That is too early to say. But what we will continue optimizing the portfolio and will guide at a later stage.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, well, I mean, look our -- in the United States, market grew about 5% in total contact lenses and we grew 7% in the U.S. So we feel good about that. I think what you see in the international markets is a decline of something on the order of 5% plus or minus a little bit and I think what we're going to try -- and again we are working hard to get our products out there, but again we're kind of right at about market growth there. So when you kind of net those, that's where you are coming up with this basically at market growth. So we think the full market around the world was flat. And we think that the -- again, we reported a minus 1%, so roughly flat.
My sense of it is, is that the biggest difference in our peer group is their exposure to markets that have already bounced back. The last year had very big declines, read China, particularly in February and March. This year had extraordinary February's and March. And so that swing which we have a lower exposure to is really I think what's happening. I understand there's some other things going on inventory and gross and net, stuff like that, but I -- again I think the big news here is just the exposure to the markets that bounce back and those that didn't and we're obviously over-indexed in Europe and in Japan, both of which are still kind of under heavy COVID pressure.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I mean -- simply I'm saying the -- we accessed the securitization market for about $500 million last year and with a lot than we did in the fourth quarter. As we look -- as others have entered the market this year investors -- those investors are looking for yield and RevPAR assets provide an attractive risk-adjusted yield to them. And so -- and that is driving -- driven spreads down coupled with low benchmarks. So that's why we're seeing the financing that we're doing. And where -- what it means for us this year. I think when we access the markets, I think they'll be favorable and we will continue to lower our cost of capital.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, Randy, this is Aaron. Great question and thank you. It's a multifaceted approach here and this really highlights the benefit and strength of our overall portfolio and that the EBITDA growth will be a function of not only the strong performance that we expect to see within Sierra and Barnes, but also the recovery of the Black Diamond brand and the achieving or getting back to that magical milestone of 10% EBITDA within Black Diamond this year. So as a result, what we're seeing is a highlighted element of how this portfolio comes together highlighting the strong performance and EBITDA profile of that of Sierra and Barnes while also being able to continue to leverage the SG&A and seeing some modest gross margin improvements associated with that of -- with Black Diamond as we continue to grow and scale the business.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So recall, I also said earlier that we had about $400 million of the $900 million in growth on the security side that came in toward the end of the quarter. That will influence the margin here early in the second quarter. It will increase net interest income to some degree as compared to five to 10 basis points the Fed, but it's lower than the normal margin, say, on a normal loan-to-deposit ratio for the company. So I would plug that into your model. We said somewhat of a reduction in terms of basis points without being specific as to whether that's two, four, whatever it is versus a few basis points and it is coming from additional reduction on the loan yield side as we book new loans in that three 18 to three 20 area that is in the deck versus what's coming off in the three 73 area. So still some repricing on that side. We have some savings yet on cost of funds, but most of that has already been factored in and won't be as much going forward as low as we are at this point.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, hi. Thanks for taking my questions. And good luck, Bryan. Jamey, I was wondering if we could just circle back one more time on the -- some of the assumptions as it relates to COVID. I guess, first you talked about how the State of California has asked you to increase capacity in that lab there. So I presume that that would also mean that you're -- basically the minimum amount of revenue you should expect to receive from that contract should increase in the first quarter versus what you saw in the fourth quarter. And then in the UK, I believe your -- larger of your two labs didn't open until the beginning of December and that has continued to ramp up we believe. So should both California and the UK contribute meaningfully more in revenue COVID revenue in the first quarter versus what you saw in the fourth quarter?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. No, it's a little bit of trimming in a couple of different areas, but primarily the removal of the discontinued ops.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
100%.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
OK. But I don't think we're change -- it's not like we're out chasing because we feel like we need to do it. We think as you look at '23, '24, it'd be nice to have the right business to fold in because of our call point and our 2,200 people in the field.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thank you. Walk us through a little bit more about what you're getting with Hargray and what can we expect kind of the trends with those subs? And in particular, talk to us a little bit about the extensive fiber network that you get with that and how that fits into your mix and what you think the opportunity is to drive business there. Thanks.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. That was actually pretty good. Good afternoon, everyone. So a quick question about same-store forecast for next year. The occupancy guidance of 90% to 92%, you were at 92% for 2020. What could kind of get you to the lower end of that range? And even if you were at the higher end, which is the same number you were at in 2020, you still kind of forecast about a flat same-store NOI growth. Can you just walk us through that a little bit.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well completely replicate the analyses that went into the original interim analysis.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, thank you. Good afternoon and thank you for taking our questions. You may proceed with your question. Hi, thank you. My first question is on Europe. And can you maybe just, Enrique, update us on how you and your partner Astellas are thinking about the cadence of establishing reimbursement into key geographies? And just how you're thinking about the launch trajectory over the next one to two years, given that, that's a potential gating factor there in Europe? And then I had a pipeline follow-up question.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. Perfect. Yeah, our new -- the new gentlemen has about 15 years of global and industry experience at 3M and Honeywell, leading innovation teams and new business development teams as well as Ranpak. So as he comes and transitions into Neenah, he just started little over a week ago, his primary focus is going to be on how we accelerate a global innovation process and really utilize the skills and know-how and knowledge of our technology teams across Neenah.
So, historically, we've been more aligned by category, which can work well, but it can also sub-optimize across Neenah. So, we might have great technology knowledge around coatings in a particular category, but we need that in another category like we might have in Tech Products, but we need it in Fine Paper as we drive new innovative products, and he is really going to help us ensure we're making the right decisions and accelerating growth across all of Neenah.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
All of the above.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Brenna [Phonetic] and thank you everyone for joining us this morning. We look forward to continued strong results in our next report toward the end of October. Thank you.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thank you very much for the presentation. Couple of questions. Firstly on the 5G, what would be your thoughts over the time you can build for the financial implications of the spectrum auction? And would you envisage the significant investments into the network after or around the spectrum allocation? And the second question would be on the electric vehicle projects. Can you outline certain potential for the further upcoming capital commitments into this project, and also the timing, the magnitude of the monetization, as well as the synergies you see with Turkcell? Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. We're very familiar with the transactions that occurred. They're both a little bit unique in certain respects. So we chose, at this point, we're going to continue to look at our opportunities.
Whether it's Bakken or wherever, I mean, Leo, we're looking for the right opportunity. We do know the Bakken, and that's where our focus is, and I expect it to remain. So yes, we can't comment too many items there.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Right. And it does take some time not only to bring in new business but also to reequip ourselves with the suitable testers does take some time for us to fully recover.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's an area of interest for us. It's an area that we are investing in, in our own capabilities, as well as partner integrations and partner capabilities as evidenced, in example, by the Plaid integration. And it's also an area that we are looking through the lens of M&A. And it's certainly an opportunity that we would like to capture value from if there's value to be captured.
But more importantly, if there's value to be captured in driving growth for our customers and helping our customers differentiate, make faster, better decisions, have a better risk management process integrated into decisioning. We're highly interested in building out that capability over time. And I believe it's also to the benefit of the greater market, not just our existing or new future customers.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So we talked previously about sort of the program itself, right, which initially was treating up to 150 patients at up to 30 sites in the U.S. The pediatric NexoBrid study was ongoing at that time. And now the enrollment is closed in that study and pediatric patients can be treated in the next study.
So the protocol was actually amended to increase the number of sites up to 35 and then up to 200 patients. And so, there's -- we're probably somewhere in the low to mid-20s in terms of the number of sites that are currently engaged in that study. There have been COVID impacts, right, where sites weren't starting new studies and so on. But we hope to continue to increase that over the balance of this time ahead of approval.
And so, we continue to enroll patients. We have plenty of room to continue to enroll more patients, which is really important, right? We want sort of the steady execution of the study up to approval so that we have the maximum number of centers and surgeons experienced with the product.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Perfect. Thank you so much, guys. Well, one question for me. I will actually -- and then a quick follow-up.
The very aggressive pace of hiring that you guys are going through right now obviously makes a ton of sense, considering the opportunity that you're going after. How -- what are you seeing as far as the productivity and the ramp in productivity within the new sales hires that you're bringing on board now?

    Prediction (one of UP, DOWN, SAME): SAME